{"id":"NCT00457691","sponsor":"Pfizer","briefTitle":"Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer","officialTitle":"A Multicenter, Randomised, Double-Blind, Phase 3 Study Of Sunitinib In Metastatic Colorectal Cancer Patients Receiving Irinotecan, 5-Fluorouracil And Leucovorin (FOLFIRI) As First Line Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-06","primaryCompletion":"2010-03","completion":"2010-03","firstPosted":"2007-04-06","resultsPosted":"2011-06-03","lastUpdate":"2015-03-30"},"enrollment":768,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Metastatic Colorectal Cancer"],"interventions":[{"type":"DRUG","name":"5 fluorouracil","otherNames":[]},{"type":"DRUG","name":"irinotecan","otherNames":[]},{"type":"DRUG","name":"levo- leucovorin","otherNames":[]},{"type":"DRUG","name":"sunitinib","otherNames":[]},{"type":"DRUG","name":"5 fluorouracil","otherNames":[]},{"type":"DRUG","name":"irinotecan","otherNames":[]},{"type":"DRUG","name":"levo- leucovorin","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to evaluate the safety and efficacy of FOLFIRI (Irinotecan, Leucovorin and 5 Fluorouracil) chemotherapy when combined with sunitinib or FOLFIRI chemotherapy without adding sunitinib as the first line treatment of patients with metastatic colorectal cancer.","primaryOutcome":{"measure":"Progression-free Survival (PFS)","timeFrame":"First dose of study treatment up to 30 months","effectByArm":[{"arm":"FOLFIRI + Sunitinib","deltaMin":33.6,"sd":null},{"arm":"FOLFIRI + Placebo","deltaMin":36.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.8072"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":132,"countries":["Argentina","Australia","Austria","Belgium","Bosnia and Herzegovina","Brazil","Bulgaria","Canada","Chile","Colombia","Cyprus","Czechia","Germany","Hong Kong","Hungary","India","Ireland","Mexico","Norway","Poland","Portugal","Romania","Russia","Serbia","Singapore","Slovakia","South Africa","South Korea","Spain","Sweden","Taiwan","Thailand","Ukraine","United Kingdom"]},"refs":{"pmids":["23358972"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6181122&StudyName=Study%20Of%20FOLFIRI%20Chemotherapy%20With%20Or%20Without%20Sunitinib%20In%20Patients%20With%20Metastatic%20Colorectal%20Cancer%0A"]},"adverseEventsSummary":{"seriousAny":{"events":170,"n":384},"commonTop":["Neutropenia","Diarrhoea","Nausea","Vomiting","Alopecia"]}}